Cargando…

Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia

BACKGROUND: Chronic lymphocytic leukemia (CLL) has been a good model system to understand the functional role of 5-methylcytosine (5-mC) in cancer progression. More recently, an oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) has gained lot of attention as a regulatory epigenetic modification...

Descripción completa

Detalles Bibliográficos
Autores principales: Wernig-Zorc, Sara, Yadav, Mukesh Pratap, Kopparapu, Pradeep Kumar, Bemark, Mats, Kristjansdottir, Hallgerdur Lind, Andersson, Per-Ola, Kanduri, Chandrasekhar, Kanduri, Meena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322269/
https://www.ncbi.nlm.nih.gov/pubmed/30616658
http://dx.doi.org/10.1186/s13072-018-0252-7
_version_ 1783385586677055488
author Wernig-Zorc, Sara
Yadav, Mukesh Pratap
Kopparapu, Pradeep Kumar
Bemark, Mats
Kristjansdottir, Hallgerdur Lind
Andersson, Per-Ola
Kanduri, Chandrasekhar
Kanduri, Meena
author_facet Wernig-Zorc, Sara
Yadav, Mukesh Pratap
Kopparapu, Pradeep Kumar
Bemark, Mats
Kristjansdottir, Hallgerdur Lind
Andersson, Per-Ola
Kanduri, Chandrasekhar
Kanduri, Meena
author_sort Wernig-Zorc, Sara
collection PubMed
description BACKGROUND: Chronic lymphocytic leukemia (CLL) has been a good model system to understand the functional role of 5-methylcytosine (5-mC) in cancer progression. More recently, an oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) has gained lot of attention as a regulatory epigenetic modification with prognostic and diagnostic implications for several cancers. However, there is no global study exploring the role of 5-hydroxymethylcytosine (5-hmC) levels in CLL. Herein, using mass spectrometry and hMeDIP-sequencing, we analysed the dynamics of 5-hmC during B cell maturation and CLL pathogenesis. RESULTS: We show that naïve B-cells had higher levels of 5-hmC and 5-mC compared to non-class switched and class-switched memory B-cells. We found a significant decrease in global 5-mC levels in CLL patients (n = 15) compared to naïve and memory B cells, with no changes detected between the CLL prognostic groups. On the other hand, global 5-hmC levels of CLL patients were similar to memory B cells and reduced compared to naïve B cells. Interestingly, 5-hmC levels were increased at regulatory regions such as gene-body, CpG island shores and shelves and 5-hmC distribution over the gene-body positively correlated with degree of transcriptional activity. Importantly, CLL samples showed aberrant 5-hmC and 5-mC pattern over gene-body compared to well-defined patterns in normal B-cells. Integrated analysis of 5-hmC and RNA-sequencing from CLL datasets identified three novel oncogenic drivers that could have potential roles in CLL development and progression. CONCLUSIONS: Thus, our study suggests that the global loss of 5-hmC, accompanied by its significant increase at the gene regulatory regions, constitute a novel hallmark of CLL pathogenesis. Our combined analysis of 5-mC and 5-hmC sequencing provided insights into the potential role of 5-hmC in modulating gene expression changes during CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13072-018-0252-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6322269
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63222692019-01-09 Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia Wernig-Zorc, Sara Yadav, Mukesh Pratap Kopparapu, Pradeep Kumar Bemark, Mats Kristjansdottir, Hallgerdur Lind Andersson, Per-Ola Kanduri, Chandrasekhar Kanduri, Meena Epigenetics Chromatin Research BACKGROUND: Chronic lymphocytic leukemia (CLL) has been a good model system to understand the functional role of 5-methylcytosine (5-mC) in cancer progression. More recently, an oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) has gained lot of attention as a regulatory epigenetic modification with prognostic and diagnostic implications for several cancers. However, there is no global study exploring the role of 5-hydroxymethylcytosine (5-hmC) levels in CLL. Herein, using mass spectrometry and hMeDIP-sequencing, we analysed the dynamics of 5-hmC during B cell maturation and CLL pathogenesis. RESULTS: We show that naïve B-cells had higher levels of 5-hmC and 5-mC compared to non-class switched and class-switched memory B-cells. We found a significant decrease in global 5-mC levels in CLL patients (n = 15) compared to naïve and memory B cells, with no changes detected between the CLL prognostic groups. On the other hand, global 5-hmC levels of CLL patients were similar to memory B cells and reduced compared to naïve B cells. Interestingly, 5-hmC levels were increased at regulatory regions such as gene-body, CpG island shores and shelves and 5-hmC distribution over the gene-body positively correlated with degree of transcriptional activity. Importantly, CLL samples showed aberrant 5-hmC and 5-mC pattern over gene-body compared to well-defined patterns in normal B-cells. Integrated analysis of 5-hmC and RNA-sequencing from CLL datasets identified three novel oncogenic drivers that could have potential roles in CLL development and progression. CONCLUSIONS: Thus, our study suggests that the global loss of 5-hmC, accompanied by its significant increase at the gene regulatory regions, constitute a novel hallmark of CLL pathogenesis. Our combined analysis of 5-mC and 5-hmC sequencing provided insights into the potential role of 5-hmC in modulating gene expression changes during CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13072-018-0252-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-07 /pmc/articles/PMC6322269/ /pubmed/30616658 http://dx.doi.org/10.1186/s13072-018-0252-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wernig-Zorc, Sara
Yadav, Mukesh Pratap
Kopparapu, Pradeep Kumar
Bemark, Mats
Kristjansdottir, Hallgerdur Lind
Andersson, Per-Ola
Kanduri, Chandrasekhar
Kanduri, Meena
Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
title Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
title_full Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
title_fullStr Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
title_full_unstemmed Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
title_short Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
title_sort global distribution of dna hydroxymethylation and dna methylation in chronic lymphocytic leukemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322269/
https://www.ncbi.nlm.nih.gov/pubmed/30616658
http://dx.doi.org/10.1186/s13072-018-0252-7
work_keys_str_mv AT wernigzorcsara globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT yadavmukeshpratap globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT kopparapupradeepkumar globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT bemarkmats globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT kristjansdottirhallgerdurlind globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT anderssonperola globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT kandurichandrasekhar globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia
AT kandurimeena globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia